\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\ \(73\)\
\-\ surgical\\ removal\\ most\\ of\\ skull\\ base\\ mass\\ on\\ right\\,\\ followed\\ by\\ gamma\\ knife\\ therapy\\.\ \(0\)\
\-\ 1\\.\\ small\\ extra\\-axial\\ mass\\ lying\\ in\\ interhemispheric\\ fissure\\ at\\ base\\ of\\ frontal\\ lobes\\.\ \(0\)\
\-\ 2\\.\\ large\\ extra\\-axial\\ dumbbell\\-shaped\\ mass\\ extending\\ from\\ the\\ right\\ cpa\\ cistern\\ across\\ petrous\\ apex\\ and\\ invading\ \(0\)\
\-\ right\\ cavernous\\ sinus\\.\\ \\ mass\\ contains\\ large\\ flow\\ voids\\ and\\ enhances\\ intensely\\ and\\ homogeneously\\.\ \(0\)\
\-\ meningioma\\,\\ multiple\ \(0\)\
\-\ \\â\\€\\¢\\ meningioma\ \(7\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ chondrosarcoma\ \(3\)\
\-\ \\â\\€\\¢\\ trigeminal\\ schwannoma\ \(0\)\
\-\ 68\\ year\\ old\\ man\\ with\\ progressive\\ hearing\\ loss\\ on\\ right\\ and\\ right\\ sided\\ facial\\ numbness\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ right\\:\\ 0\\.22892221397536452\ \(0\)\
\-\ mass\\:\\ 0\\.21099550398449715\ \(0\)\
\-\ base\\:\\ 0\\.2100936709968936\ \(0\)\
\-\ meningioma\\:\\ 0\\.20695621289662855\ \(0\)\
\-\ cpa\\:\\ 0\\.16634407188914582\ \(0\)\
\-\ interhemispheric\\:\\ 0\\.16510232359604063\ \(0\)\
\-\ intensely\\:\\ 0\\.16510232359604063\ \(0\)\
\-\ invading\\:\\ 0\\.1606885403784019\ \(0\)\
\-\ petrous\\:\\ 0\\.15610722165359042\ \(0\)\
\-\ knife\\:\\ 0\\.15297916273418896\ \(0\)\
\-\ trigeminal\\:\\ 0\\.15297916273418896\ \(0\)\
\-\ gamma\\:\\ 0\\.1489349864541588\ \(0\)\
\-\ homogeneously\\:\\ 0\\.143908289887416\ \(0\)\
\-\ voids\\:\\ 0\\.1415094196122677\ \(0\)\
\-\ lying\\:\\ 0\\.1389131357149312\ \(0\)\
\-\ large\\:\\ 0\\.13838561485952405\ \(0\)\
\-\ fissure\\:\\ 0\\.1347744552777977\ \(0\)\
\-\ across\\:\\ 0\\.13443106251077244\ \(0\)\
\-\ contains\\:\\ 0\\.13443106251077244\ \(0\)\
\-\ cistern\\:\\ 0\\.13409247259748147\ \(0\)\
\-\ 68\\:\\ 0\\.13278357090717396\ \(0\)\
\-\ apex\\:\\ 0\\.12979102732698472\ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.1266288715228365\ \(0\)\
\-\ hearing\\:\\ 0\\.12542420587803632\ \(0\)\
\-\ numbness\\:\\ 0\\.12275632184388155\ \(0\)\
\-\ enhances\\:\\ 0\\.12172600532413423\ \(0\)\
\-\ cavernous\\:\\ 0\\.11978826868982569\ \(0\)\
\-\ schwannoma\\:\\ 0\\.11834253862624283\ \(0\)\
\-\ lobes\\:\\ 0\\.11521979622913531\ \(0\)\
\-\ and\\:\\ 0\\.11414315384128755\ \(0\)\
\-\ facial\\:\\ 0\\.11387035059338035\ \(0\)\
\-\ skull\\:\\ 0\\.1120450562613934\ \(0\)\
\-\ progressive\\:\\ 0\\.10576647018063265\ \(0\)\
\-\ removal\\:\\ 0\\.10555866818225243\ \(0\)\
\-\ sinus\\:\\ 0\\.09978702717234801\ \(0\)\
\-\ available\\:\\ 0\\.09369395532923644\ \(0\)\
\-\ extending\\:\\ 0\\.09363066435418518\ \(0\)\
\-\ followed\\:\\ 0\\.09325435443256616\ \(0\)\
\-\ flow\\:\\ 0\\.09198150943105132\ \(0\)\
\-\ frontal\\:\\ 0\\.08888209572625452\ \(0\)\
\-\ sided\\:\\ 0\\.08883020120655805\ \(0\)\
\-\ loss\\:\\ 0\\.08413296969936944\ \(0\)\
\-\ on\\:\\ 0\\.0834145516020921\ \(0\)\
\-\ therapy\\:\\ 0\\.07934494377704476\ \(0\)\
\-\ metastatic\\:\\ 0\\.07573859063499368\ \(0\)\
\-\ man\\:\\ 0\\.07310958525037843\ \(0\)\
\-\ most\\:\\ 0\\.07186919095398314\ \(0\)\
\-\ small\\:\\ 0\\.07123441981701395\ \(0\)\
\-\ multiple\\:\\ 0\\.0675456189076362\ \(0\)\
\-\ surgical\\:\\ 0\\.06711902136386\ \(0\)\
\-\ by\\:\\ 0\\.058643449072276234\ \(0\)\
\-\ disease\\:\\ 0\\.05796767456847004\ \(0\)\
\-\ from\\:\\ 0\\.05484576268512806\ \(0\)\
\-\ not\\:\\ 0\\.0545169026707163\ \(0\)\
\-\ of\\:\\ 0\\.05404943971648959\ \(0\)\
\-\ at\\:\\ 0\\.052160499171118396\ \(0\)\
\-\ year\\:\\ 0\\.042558379976470447\ \(0\)\
\-\ old\\:\\ 0\\.040870776726237\ \(0\)\
\-\ in\\:\\ 0\\.03435373170275634\ \(0\)\
\-\ the\\:\\ 0\\.02755509866212541\ \(0\)\
\-\ with\\:\\ 0\\.02704086712192046\ \(0\)\
